Nazione: Regno Unito
Lingua: inglese
Fonte: DrWeigert
Dr. Weigert
Date revised: 06.12.2016 Print date: 26.05.17 3 / GB- 800005-003-02 Version: 3 / GB Replaces Version: 2 / GB SAFETY DATA SHEET IN ACCORDANCE WITH REGULATION (EC) NO 1907/2006 NEOMOSCAN G 8 Page 1(7) SECTION 1: IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE COMPANY/UNDERTAKING 1.1. PRODUCT IDENTIFIER neomoscan G 8 1.2. RELEVANT IDENTIFIED USES OF THE SUBSTANCE OR MIXTURE AND USES ADVISED AGAINST USE OF THE SUBSTANCE/PREPARATION Lubricants, greases and release products 1.3. DETAILS OF THE SUPPLIER OF THE SAFETY DATA SHEET ADDRESS: Chemische Fabrik Dr. Weigert GmbH & Co. KG Mühlenhagen 85 D-20539 Hamburg Telephone no. +49 40 789 60 0 Fax no. +49 40 789 60 120 www.drweigert.com E-MAIL ADDRESS OF PERSON RESPONSIBLE FOR THIS SDS: sida@drweigert.de 1.4. EMERGENCY TELEPHONE NUMBER GBK/ Infotrac: (USA domestic) 1 800 535 5053 or international +1 352 323 3500 SECTION 2: HAZARDS IDENTIFICATION 2.1. CLASSIFICATION OF THE SUBSTANCE OR MIXTURE This product is not classified hazardous in accordance with Regulation (EC) No 1272/2008. 2.2. LABEL ELEMENTS LABELLING ACCORDING TO REGULATION (EC) NO 1272/2008 HAZARD STATEMENTS EUH210 Safety data sheet available on request. HAZARDOUS COMPONENT(S) TO BE INDICATED ON LABEL (REGULATION (EC) NO. 1272/2008) EUH208 Contains A mixture of: 5-Chloro-2-methyl-2h-isothiazol-3-one [EC-no. 247-500-7] and 2- Methyl-2H-isothiazol-3-one [EC-no. 220-239-6] (3:1), May produce an allergic reaction. 2.3. OTHER HAZARDS No special hazards have to be mentioned. SECTION 3: COMPOSITION/INFORMATION ON INGREDIENTS 3.2. MIXTURES SECTION 4: FIRST AID MEASURES 4.1. DESCRIPTION OF FIRST AID MEASURES GENERAL INFORMATION In case of persistent symptoms consult doctor. AFTER INHALATION Ensure supply of fresh air. In the event of symptoms take medical treatment. Date revised: 06.12.2016 Print date: 26.05.17 3 / GB- 800005-003-02 Version: 3 / GB Replaces Version: 2 / GB SAFETY DATA SHEET IN ACCORDANCE WITH REGULATION (EC) NO 1907/2006 NEOMOSCAN G 8 Page 2(7) AFTER SKIN CONTACT In case of contact with skin wash off w Leggi il documento completo
Leggi il documento completo